US EditionWhy Life Sciences Should Exempt Tariffs
Summary by In-sightpublishing.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Why Life Sciences Should Exempt Tariffs
Author(s): Scott Douglas Jacobsen Publication (Outlet/Website): BioAro Publication Date (yyyy/mm/dd): 2025 Dr. Anmol Kapoor, MD, a cardiologist, healthcare innovator, and BioAro founder, advocates excluding life sciences from U.S. tariffs. He highlights the U.S.-Canada healthcare interdependence and warns that tariffs could disrupt medical innovation, increase costs, and delay treatment access. Kapoor stresses the need for stronger cross-border …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
